Rarediseases

Rare diseases information and resources are provided online.

About Rarediseases

Rarediseases is a Government & Social Sector company. Rare diseases information and resources are provided online. Its website rarediseases.org draws about 536 thousand monthly visits. Its focus areas include Healthcare and Healthcare Foundations. Its legal entity is National Organization for Rare Disorders, Inc.

Company details

An online platform focused on rare diseases is maintained by Rarediseases through the domain rarediseases.org. Educational materials, patient support resources, and awareness initiatives are offered to affected individuals and healthcare providers. Operations center on digital dissemination of factual content about rare disorders, with no specific geographic location indicated. The sector involves healthcare information services, emphasizing accessibility for global users without physical offices noted.

  • Sectors
    Government & Social Sector
  • Website category Health · Health Conditions and Concerns
  • Website rarediseases.org
  • Social LinkedIn X Facebook YouTube
  • Legal Name National Organization For Rare Disorders, Inc
Key Metrics
  • Latest Funding Round
    $1.39M (USD), Grant

    Aug 2008

  • Investors
    HHS

    & 1 more

Apps and channels of Rarediseases

its YouTube channel National Organization for Rare Disorders (NORD) has 6.91K subscribers and 30 videos.

National Organization for Rare Disorders (NORD)
YouTube 6.91K subscribers 30 videos Nonprofits & Activism
Open channel

Videos from Rarediseases

The most watched videos on Rarediseases's YouTube channel, National Organization for Rare Disorders (NORD) (6.91K subscribers). Click a video to play it here.

Hypertrophic Cardiomyopathy Explained: Symptoms, Causes & Treatments
3K views
Mastocytosis Explained: Symptoms, Types, and Diagnosis
2.4K views
Eosinophilic granulomatosis with polyangiitis (EGPA): Signs, Symptoms & the Path to Remission
2.4K views
Living with Median Arcuate Ligament Syndrome (MALS): Symptoms and What to Know
2.4K views

More on National Organization for Rare Disorders (NORD).

Funding Insights of Rarediseases

  • Total Rounds 2
  • Last Round Grant β€” $1.39M
  • First Round $25,000

    (Mar 2008)

  • Investors Count 2

All 2 funding rounds of Rarediseases with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2008$1.39MGrant––
Mar 2008$25,000Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Rarediseases

Rarediseases has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and U.S. Department of Education.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Education promotion is managed by the federal agency ED.
1980ed.gov
Premium access

Investor details for Rarediseases

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Rarediseases

31 people are tracked at Rarediseases (11 in leadership, 14 in board & advisors, 6 in team).

NameRoleGroup
Pamela Gavin
Chief Executive OfficerLeadership
Jill L. Pollander
VP, Patient ServicesLeadership
Prashant Goel
VP, Information TechnologyLeadership
Norine Schwarzchild
VP, Human ResourcesLeadership
Edward Neilan
Chief Medical & Scientific OfficerLeadership
Kelly Esperias
Chief Strategy & Operations OfficerLeadership
Jackie Avial
Director Of Content, Marketing & CommunicationsLeadership
Janine Lewis
Director Of Research OperationsLeadership
Marybeth Mcafee
Director Of Medical AffairsLeadership
Kasey Baker
Associate Director Of TechnologyLeadership
Cheryl Herbert
Vice President Of Marketing & CommunicationsLeadership
Shafali Spurling Jeste
DirectorBoard & advisors
Phillip L. Pearl
DirectorBoard & advisors
Kay Holcombe
ChairBoard & advisors
Jim Palma
SecretaryBoard & advisors
Susan A. Berry
DirectorBoard & advisors
Mark Skinner
DirectorBoard & advisors
Leon Eidelman
DirectorBoard & advisors
Dennis Jackman
Vice ChairBoard & advisors
Mike Porath
DirectorBoard & advisors

11 more people are available in the full profile.

Premium access

Complete people profiles for Rarediseases

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Rarediseases

2 dated milestones of Rarediseases, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $25K.
  2. Funding Latest funding round, Grant, of $1.4M.

Web traffic of Rarediseases

The website of Rarediseases (rarediseases.org) receives about 535.9K visits a month and ranks #113,304 among all websites worldwide, #3,322 in Health Conditions and Concerns.

  • Monthly visits
    535.9K

    ▲ 3.5% vs previous month

  • Unique visitors
    296.4K

    per month

  • Global rank
    #113,304

    among all websites

  • Category rank
    #3,322

    Health · Health Conditions and Concerns

Similar websites

Websites whose visitors overlap most with Rarediseases. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
globalgenes.org
globalgenes.org
100%
#947,716–
eurordis.org
97%
56.8K#660,296View details
rarediseaseday.org
rarediseaseday.org
94%
#802,104–
orpha.net
orpha.net
91%
#75,870–
checkorphan.org
checkorphan.org
87%
#1,951,359–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Rarediseases

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rarediseases

An online platform focused on rare diseases is maintained by Rarediseases through the domain rarediseases.org. Educational materials, patient support resources, and awareness initiatives are offered to affected individuals and healthcare providers. Operations center on digital dissemination of factual content about rare disorders, with no specific geographic location indicated. The sector involves healthcare information services, emphasizing accessibility for global users without physical offices noted.

Rarediseases has 2 investors. Key investors include HHS, and U.S. Department of Education.

Rarediseases operates through National Organization For Rare Disorders, Inc.

The website of Rarediseases receives about 536 thousand visits a month and ranks #113,304 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available